Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors
about
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaB-cell survival factors in autoimmune rheumatic disordersEffect of TACI signaling on humoral immunity and autoimmune diseasesMechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary ImmunodeficienciesUnbalanced Immune System: Immunodeficiencies and AutoimmunityAutoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management.B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.Differences in mouse and human nonmemory B cell pools.The function of BAFF on T helper cells in autoimmunityThe strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF).Comparative analysis of virus-host interactions caused by a virulent and an attenuated duck hepatitis A virus genotype 1The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation.BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) miceCurrent and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.Nfkb1 activation by the E26 transformation-specific transcription factors PU.1 and Spi-B promotes Toll-like receptor-mediated splenic B cell proliferation.TACI expression and signaling in chronic lymphocytic leukemiaChanges in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cellsMolecular signature in HCV-positive lymphomasPartial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE).Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival.DNP-KLH Yields Changes in Leukocyte Populations and Immunoglobulin Isotype Use with Different Immunization Routes in Zebrafish.Expression of BAFF and BR3 in patients with systemic lupus erythematosus.Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturationBAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapyB-cell activating factor (BAFF) is elevated in chronic granulomatous disease.CVID-associated TACI mutations affect autoreactive B cell selection and activation.Interferon-driven deletion of antiviral B cells at the onset of chronic infection.IFN type I and II induce BAFF secretion from human decidual stromal cells.Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.Viral-host interaction in kidney reveals strategies to escape host immunity and persistently shed virus to the urine.Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to dateB cells and antibodies in multiple sclerosis pathogenesis and therapy.The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus.Is rituximab effective in childhood nephrotic syndrome? Yes and no.Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus.Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.
P2860
Q26784444-84F173ED-7EEA-47FC-BD2A-3BDF0046C994Q26796484-3F0A695D-12E1-4536-B916-9E7FB5E86534Q26995571-4CD81A44-5F6F-493C-B4AC-01D95700DF67Q28066193-30C5EA13-B4B1-45BA-946A-8F7BB6484280Q28075911-C0717794-5689-40C4-A9EC-33618ABF7B12Q30245322-9A8C01B6-7905-4259-8573-F396DF751BFAQ33404838-84D61699-9CEC-46F4-932C-BD1B041A7DABQ33412584-B08CD550-606B-4D32-95C9-5C6A34AB9E47Q33418352-FC54368B-89FE-411A-BC0D-A8D512EFE4FEQ33716235-0FD42559-9172-4B6A-B583-29A87D4EF35EQ33748041-E0B4C69E-EEED-4201-B36A-94CD7FD325F5Q33792424-955F88ED-36A1-44B5-85AE-B4232DC93AC2Q33797482-82A1C4C5-C157-4813-B659-DC1993285FC5Q34652175-0FED50A9-094A-4454-9866-733AF938F533Q34656412-80BD2C63-B6B8-4094-88CE-B57FA8AC1406Q34960458-B7EE2786-931D-4767-BB61-912B4C7137DBQ35288509-386E58CE-DCD6-49F5-BE34-097F245B991FQ35534809-3B285E4C-B6C0-43E3-83D0-E7B621CCBDEAQ35850791-5E0EDAD5-0866-4D41-AAD2-A0770592D40FQ36165173-D613C184-491A-4358-AEFC-01847469738CQ36199986-930CAB52-78FD-4FB9-B79E-C96A03DB3511Q36253983-45F6D029-75B0-4452-9B0D-B6B9482B6028Q36271212-659AFD0C-6C91-4C22-BB3C-BE7991EB2195Q36279914-AF4CBACF-5A69-486F-9FE1-23105BEF096DQ36332734-C9E756D5-83F0-45FD-AF6D-BFE7FEC13ABFQ36607723-229F2B6C-8064-46A5-B55A-7B2846B5544CQ36626153-F2A35780-C142-4871-AF4C-37943C5BEFEDQ36722422-C99CE706-CDB7-4837-BDB1-54DD6A3C388CQ37174792-855FF6EC-29A0-43D9-B027-40617200F63AQ37206886-47EF7A12-E38F-489D-88A0-016F3BC0AF9FQ37423183-DB7C10DD-B023-4D26-B53E-C544B78E8C27Q37563438-7CEBA250-1CC7-4903-8076-50AD03C64F58Q37700864-B039C2F8-226D-4B8E-92C9-081868A456A7Q37702518-AE18A5A3-A312-42E9-9F51-9EB65D45349BQ37709763-1C8ED04C-21FA-4213-A467-9BD4BA1C2E17Q38050398-61B72E09-87DC-45FD-85B2-90A0A9566A24Q38095861-9D9C33E5-8B92-4EAA-ACDC-8925A35F4701Q38118894-77F95830-EDE3-4EF6-B4D3-94B61724EFCFQ38187489-BA0B2F2F-F85B-4F31-B6BF-033C531AC416Q38211700-3A67DA1A-9919-4446-9C22-717635ED25D5
P2860
Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@ast
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@en
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@nl
type
label
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@ast
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@en
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@nl
prefLabel
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@ast
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@en
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@nl
P2093
P3181
P356
P1476
Soluble BAFF levels inversely ...... e expression of BAFF receptors
@en
P2093
Alessandro Plebani
Antonius G Rolink
Bodo Grimbacher
Hermann Eibel
Isabella Quinti
Jennifer Birmelin
Jens Thiel
Klaus Warnatz
Marta Rizzi
Matthias Kreuzaler
P304
P3181
P356
10.4049/JIMMUNOL.1102321
P407
P50
P577
2011-11-28T00:00:00Z